Seven Eight Capital, LP Bio Rad Laboratories, Inc. Transaction History

Seven Eight Capital, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$304.11 - $351.99 $599,704 - $694,124	1,972 Added 69.14%	4,824 $1.67 Million
Q4 2023 Feb 13, 2024	BUY	$269.37 - $365.04 $181,824 - $246,402	675 Added 31.01%	2,852 $920,000
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $762,494 - $920,065	2,177 New	2,177 $780,000
Q2 2022 Aug 04, 2022	SELL	$463.67 - $597.16 $501,227 - $645,529	-1,081 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$524.57 - $735.42 $567,060 - $794,989	1,081 New	1,081 $609,000
Q2 2019 Aug 12, 2019	SELL	$286.93 - $312.59 $705,560 - $768,658	-2,459 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $551,553 - $780,511	2,459 New	2,459 $752,000
Q4 2017 Feb 12, 2018	SELL	$216.94 - $271.3 $542,350 - $678,250	-2,500 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$212.27 - $242.28 $488,221 - $557,244	2,300 Added 1150.0%	2,500 $556,000
Q2 2017 Aug 10, 2017	BUY	N/A	200	200 $45,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.